NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues declined 10 percent year over year.

For the three months ended September 30, the Temple City, California-based genetic testing firm reported revenues of $4.5 million compared to $5.0 million in the prior-year quarter, short of analysts' average estimate of $5.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.